Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KLHL23 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
mRNA | DOCK8 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-07 |
mRNA | BCL2 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
mRNA | ZNF616 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | PCYT1B | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | MRPS18B | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-07 |
mRNA | XKR7 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | SNN | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
mRNA | TYROBP | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
mRNA | ELAVL4 | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-07 |